Noncommunicable Diseases

A Compendium
Herausgeber: Banatvala, Nick; Bovet, Pascal

• Broschiertes Buch

Produktbeschreibung

Focusing on cardiovascular disease, diabetes, cancer, and chronic respiratory disease, and their five shared main risk factors (tobacco use, harmful use of alcohol, unhealthy diet, physical inactivity and air pollution), this book provides a synopsis of one of the worldâ s biggest challenges of the 21st century.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis Ltd
• Seitenzahl: 490
• Erscheinungstermin: 30. Januar 2023
• Englisch
• Abmessung: 234mm x 156mm x 26mm
• Gewicht: 734g
• ISBN-13: 9781032307923
• ISBN-10: 1032307927
• Artikelnr.: 66267190

Autorenporträt

Nick Banatvala is the head of the Secretariat of the United Nations Inter-Agency Task Force on the Prevention and Control of Non-communicable Diseases, in WHO, Geneva, that was established to bring the United Nations system and other inter-governmental organizations together to support governments in meeting the NCD-related Sustainable Development Goal targets. Nick is also an honorary professor at the University of Manchester, United Kingdom and honorary Senior Lecturer at Imperial College London. Pascal Bovet is a senior consultant and former professor of public health at the University Centre for Primary Care and Public Health (Unisanté) in Lausanne, Switzerland, and former head of the NCD Section and co-director of the WHO Collaborating Centre on Cardiovascular Diseases in Populations in Transition. Pascal has for many years advised governments across the world on preventing and controlling NCDs.

Inhaltsangabe

Part 1: Describing and Measuring the Burden and Impact of NCDs 1. Global
Burden of NCDs 2. Epidemiologic and Demographic Transition as Drivers of
NCDs 3. NCDs and Sustainable Development 4. Surveillance of NCDs and their
Risk Factors: Principles 5. Surveillance of NCDs and their Risk Factors:
Selected Tools Part 2: Burden, Epidemiology and Priority Interventions for
Individual NCDs 6. Cardiovascular Disease: Burden, Epidemiology and Risk
Factors 7. Cardiovascular Disease: Priority Interventions 8. Hypertension:
Burden, Epidemiology and Priority Interventions 9. Diabetes: Burden,
Epidemiology and Priority Interventions 10. Obesity: Burden, Epidemiology
and Priority Interventions 11. Cancer: Burden, Epidemiology and Principles
for Priority Interventions 12. Breast Cancer: Burden, Epidemiology and
Priority Interventions 13. Cervical Cancer: Burden, Epidemiology and
Priority Interventions 14. Colorectal Cancer: Burden, Epidemiology and
Priority Interventions 15. Prostate Cancer: Burden, Epidemiology and
Priority Interventions 16. Chronic Respiratory Diseases: Burden,
Epidemiology and Priority Interventions Part 3: Social Determinants and
Risk Factors for NCDs and Priority Interventions 17. Social Determinants of
Health and NCDs 18. Tobacco Use: Burden, Epidemiology and Priority
Interventions 19. Unhealthy Diets: Burden, Epidemiology and Priority
Interventions 20. Cholesterol, Saturated Fats and Trans Fats: Burden,
Epidemiology and Priority Interventions 21. Dietary Salt and NCDs: Burden,
Epidemiology and Priority Interventions 22. Dietary Sugars and NCDs:
Burden, Epidemiology, and Priority Interventions 23. Food Reformulation for
NCD Prevention and Control 24. Nutrition Labelling for NCD Prevention and
Control 25. Physical Inactivity and NCDs: Burden, Epidemiology, and
Priority Interventions 26. Harmful Use of Alcohol and NCDs: Burden,
Epidemiology and Priority Interventions 27. Air Pollution and NCDs: Burden,
Epidemiology and Priority Interventions 28. Infectious Diseases and NCDs
29. Genetics and NCDs Part 4: Global Policy for NCD Prevention and Control
30. The WHO Global Strategy for the Prevention and Control of NCDs 2000 31.
United Nations High-Level Meetings on NCD Prevention and Control 32. The
WHO Global Action Plan for the Prevention and Control of NCDs 2013-2030 33.
The WHO Framework Convention on Tobacco Control and Protocol to Eliminate
Illicit Trade in Tobacco Products 34. Best Buys and other Recommended
Interventions for NCD Prevention and Control 35. Accountability for NCD
Prevention and Control Part 5: Cross Cutting Issues around NCD Prevention
and Control 36. Population and Individual Approaches for NCD Prevention and
Control 37. A Life-Course Approach for NCD Prevention and Control 38.
Universal Health Coverage and NCD Prevention and Control 39. Financing and
Allocating Resources for NCD Prevention and Control 40. Making the Economic
Case for Investing in NCD Prevention and Control 41. Fiscal Measures for
NCD Prevention and Control 42. Strengthening Health Systems and Service
Delivery for NCD Prevention and Control 43. Screening and Health Checks for
NCD Prevention and Control 44. Access to Medicines for NCD Prevention and
Control 45. Access to Medical Technologies for NCD Prevention and Control
46. Law and NCD Prevention and Control 47. Changing Behaviour at Scale to
Prevent NCDs 48. Promoting Health Behaviours at the Individual Level for
NCD Prevention and Control 49. Digital Technologies for NCD Prevention and
Control 50. Effective Communication for NCD Prevention and Control 51. NCD
Prevention and Control in Emergencies and Humanitarian Settings 52. The
Role of Human Rights in NCD Prevention and Control Part 6: Stakeholder
Action for NCD Prevention and Control 53. Whole-of-Government Response for
NCD Prevention and Control 54. Whole-of-Society Response for NCD Prevention
and Control 55. The Role of People Living with NCDs in NCD Prevention and
Control 56. The Role of the Private Sector in NCD Prevention and Control
57. The Role of Public-Private Partnerships in NCD Prevention and Control
58. Aid Effectiveness and the Role of Multilateral and Bilateral
Development Agencies in NCD Prevention and Control 59. Leadership for NCD
Prevention and Control